Herantis Pharma Oyj

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: FI4000087861

EUR

2.13

-6.32 (-74.79%)

Dec 05

HEL

Click here to see other stocks

Company CV

About Herantis Pharma Oyj

stock-summary

Herantis Pharma Oyj

Pharmaceuticals & Biotechnology

Herantis Pharma Oyj is a Finland-based drug development Company with the purpose to evolve the treatment of diseases with unmet clinical needs, such as Parkinson’s disease and secondary lymphedema. The Company's product development portfolio includes: CDNF for Parkinson’s disease, Lymfactin in breast cancer-associated secondary lymphedema and Non-invasive xCDNF in neurodegenerative diseases.

Company Coordinates

Company Details

Bertel Jungin aukio 1 , ESPOO None : 02600

stock-summary

Tel: 358 9 2221195

stock-summary

http://herantis.com

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Board of Directors

Management

Designation

Mr. Pekka Mattila

Chairman of the Board

Mr. Timo Veromaa

Vice Chairman of the Board

Dr. James Phillips

Director

Mr. Aki Prihti

Director

Mr. Frans Wuite

Director

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 51 Million ()

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-1.04

Return on Equity

-311.84%

Price to Book

29.34